Skip to main navigation Skip to search Skip to main content

Mechanistic Modeling in Hematology to Systematically Explore Factors Contributing to Differences in anti-CD20 Therapy Outcomes and to Inform Optimal anti-CD20 Combination Strategies

Project: Research

Project Details

StatusFinished
Effective start/end date12/17/1412/31/18

Funding

  • F Hoffmann-La Roche Limited: $422,076.00